LumaBridge


LumaBridge is an oncology-focused clinical contract research organization (CRO) that provides outsourced clinical trial services for emerging biopharma and biotech companies. Founded in 2014 (originally Cancer Insight), the company offers end-to-end support for immuno-oncology development including trial design, regulatory strategy, clinical operations, data management, biostatistics, and safety monitoring. LumaBridge also supports government- and military-funded studies and partners with academic networks to accelerate immunotherapy development.

Industries

Customer Service
Emerging Markets
Health Care
Market Research
Research Services

Nr. of Employees

medium (51-250)

LumaBridge


Products

Full support of outsourced clinical trials

Comprehensive oncology CRO services providing assistance across the entire continuum of clinical development, advancing novel immunotherapies.

Medical Monitoring and Pharmacovigilance

Patient safety management throughout the trial life cycle by experienced medical monitors.

Medical Writing and Biostatistics

Accurate, relevant, and informative statistical reports and trial design schemas.

Regulatory Affairs and Strategy

Compliant regulatory submissions and FDA-facing strategy to accelerate time to market.

Clinical Operations

Management of all clinical trial logistics, site feasibility, and patient recruitment with certified professionals.

Clinical Data Management

Structured, validated, and meaningful information management from database build through lock.

View All Products

Services

Consulting and operational delivery across trial design, site management, monitoring, data capture, regulatory submissions, statistical analysis, and safety monitoring for oncology sponsors.

Pre-IND meetings and preparation, IND submission and maintenance, FDA liaison, and support for expedited program designations.

Database build and validation, data cleaning and coding, creation of analysis datasets, statistical analysis and reporting, and publication support.

Ongoing medical oversight, SAE processing and narratives, safety analyses and integrated summaries, and DMC management.

Timeline and milestone planning, vendor selection and contracting, financial analysis, and vendor oversight.

Clinical development and commercialization strategies tailored to Cancer Prevention and Research Institute of Texas applicants to improve funding competitiveness.

View All Services

Expertise Areas

  • Immuno-oncology clinical trial design
  • Clinical trial management
  • Regulatory strategy and IND preparation
  • Clinical data management and standards (SDTM/ADaM)
  • Show More (6)

Key Technologies

  • Electronic case report forms (eCRF)
  • Clinical trial database design and configuration
  • SAS statistical programming
  • SDTM and ADaM data standards
  • Show More (3)

News & Updates

Announcement that Avance Clinical acquired LumaBridge to expand Avance's U.S. presence and oncology capabilities.

Majority growth investment from Summit Partners to support expansion of LumaBridge's clinical trial services for emerging biopharma companies.

Strategic partnership with the Parker Institute to provide affiliated researchers with access to LumaBridge's suite of clinical trial services.

Corporate rebranding announcement: Cancer Insight changed its corporate identity to LumaBridge and described the company's continued focus on immuno-oncology trials.

Announcement of Amanda Ferrier joining LumaBridge as Chief Operating Officer to support clinical operations and organizational growth.

Announcement of Todd Lehman joining LumaBridge as Vice President and Head of Business Development to support commercial growth.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.